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Structural evidence for the role 
of polar core residue Arg175 in 
arrestin activation
Joachim Granzin1, Andreas Stadler2, Anneliese Cousin1, Ramona Schlesinger3 & Renu Batra-
Safferling1
Binding mechanism of arrestin requires photoactivation and phosphorylation of the receptor 
protein rhodopsin, where the receptor bound phosphate groups cause displacement of the long 
C-tail ‘activating’ arrestin. Mutation of arginine 175 to glutamic acid (R175E), a central residue in 
the polar core and previously predicted as the ‘phosphosensor’ leads to a pre-active arrestin that is 
able to terminate phototransduction by binding to non-phosphorylated, light-activated rhodopsin. 
Here, we report the first crystal structure of a R175E mutant arrestin at 2.7 Å resolution that reveals 
significant differences compared to the basal state reported in full-length arrestin structures. These 
differences comprise disruption of hydrogen bond network in the polar core, and three-element 
interaction including disordering of several residues in the receptor-binding finger loop and the 
C-terminus (residues 361–404). Additionally, R175E structure shows a 7.5° rotation of the amino and 
carboxy-terminal domains relative to each other. Consistent to the biochemical data, our structure 
suggests an important role of R29 in the initial activation step of C-tail release. Comparison of the 
crystal structures of basal arrestin and R175E mutant provide insights into the mechanism of arrestin 
activation, where binding of the receptor likely induces structural changes mimicked as in R175E.
Members of arrestin family play a central role in the regulation of signaling and trafficking of G 
protein-coupled receptors (GPCRs)1,2. The multistep process involves a rapid phosphorylation of the 
receptor protein followed by high affinity binding of arrestin that sterically blocks the interaction 
between receptor and G-protein, leading to the signal termination. A widely studied system to inves-
tigate the molecular mechanism of GPCR-arrestin interaction is the visual signaling cascade. Visual 
arrestin-1 (arr-1) is proposed to exist in basal or inactive form (Fig. 1a) that gets activated upon inter-
action with light-activated, phosphorylated rhodopsin (P-Rh*). Arr-1 preferentially and selectively binds 
P-Rh*, although it also binds weakly to dark P-Rh, as well as light-activated rhodopsin (Rh*). Previous 
mutagenesis reports have identified polar core residues in arrestin (R175, D30, D296, D303, R382) which 
when substituted result in mutants that can bind to light-activated rhodopsin independent of phospho-
rylation3–5. The respective residues are involved in the formation of an extended hydrogen bond network 
embedded between the two domains of arrestin that is structurally conserved in arrestin family (Fig. 2a). 
Here, residues R175 and D296 form the central salt bridge in the polar core and charge reversal of these 
residues results in arrestins that bind to the non-phosphorylated, activated receptor3,5,6. A combination 
of the reversed charges (R175E + D296R) restores the selectivity towards P-Rh*, that led these authors to 
propose R175 as the phosphate sensor residue where disruption of the polar core via receptor-attached 
phosphates is required to convert arrestin into the so-called ‘high-affinity’ state. Another interaction that 
requires breaking up for arrestin activation is the so-called three-element interaction between β -strand 
I, α -helix I (in the N-domain), and the C-tail (Fig.  1a)7. In basal state, the C-tail folds back onto the 
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N-domain in an extended conformation, closely interacting with the two elements and ending on the top 
of the polar core8–12. Mutagenesis of residues mediating the three-element interaction also yield arrestins 
that show dramatically lowered selectivity towards P-Rh* and are active7. Thus, an intact polar core and 
the three-element interactions are the constraints that keep arrestin in its inactive state.
High-resolution structures are available of several members of the arrestin family in the basal (inac-
tive) state8–12. Recently, crystal structures of the ‘pre-active’ splice variant p4413,14 and of β -arrestin bound 
to a GPCR phosphopeptide have been published15. In the presented work, we made a point muta-
tion R175E in the full-length bovine arr-1 (aa 1–404, PDB ID 3UGX) background using site-directed 
mutagenesis. The purified mutant protein R175E was subjected to crystallization studies and small-angle 
X-ray scattering (SAXS) measurements in solution. Compared to the inactive arr-1, crystal structure as 
well as SAXS solution studies of the pre-active mutant R175E reveal remarkable conformational differ-
ences described below.
Results and Discussion
Crystal structure. The mutant arrestin R175E was expressed in Saccharomyces cerevisae F11 α strain 
and purified as described in methods. R175E crystallized in space group P212121, with one molecule per 
asymmetric unit. Detailed statistics on data collection and refinement are documented in Table 1. The 
structure was solved by molecular replacement method as described in methods, which could be refined 
up to 2.7 Å resolution. The final monomer model comprises residues 11–360 (Fig.  1b). Residues 1–10 
(N-terminus), 69–75 (loop V-VI or finger loop) and 361–404 (C-terminal residues including the C-tail) 
could not be traced in the electron density maps and thus are likely to be disordered. The mutation of 
residue 175 from arginine to glutamic acid (R175E) is verified in the electron density map of the mutant 
crystal structure (Supplementary Fig. S1). Binding characteristics of the purified R175E protein was 
examined for its property to bind different forms of rhodopsin using the pull-down binding assays in 
comparison to the wild type arr-1. In agreement with the previous reports4,16, the mutant arrestin R175E 
is pre-activated as it shows binding to P-Rh*, P-Rh and Rh* (Supplementary Fig. S2).
The overall structure of R175E core is similar to the previously reported arrestin structures compris-
ing the typical bilobed structure with N- and C-domains, each consisting of eight stranded β -sandwich. 
A single α -helix is present in the N-domain and the polar core residues are located in the fulcrum of 
the domain interface (Fig.  1b). Predicted as the ‘phosphosensor’ and central residue of the hydrogen 
bond network in the polar core region, mutation of R175 to E is expected to have a severe impact on 
the structure.
Polar core. The region is composed of several charged residues that form a hydrogen bond net-
work and is highly conserved among members of the arrestin family. R175 forms a central salt bridge, 
Figure 1. Comparison of overall conformations between arr-1 and R175E. (a) Ribbon representation of 
arr-1 (PDB ID 3UGX, molecule A) where C-tail is highlighted in green and the missing residues 360–370 
are shown as dotted line (b) R175E (c) superposition of N-domains of arr-1 (gold) and R175E (blue) shows 
a 7.5° rotation in C domain of the mutant arrestin. Double-headed arrows indicate the rotation shift in the 
individual β -strands. Compared to panels a and b, the view here is rotated by 90° along the horizontal axis 
with the reader’s view upon receptor-binding concave surface. Arginine and mutated residue glutamic acid at 
position 175 are shown in stick model.
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restrained by D296 and D30 (Fig. 2a). The hydrogen bond network in the polar core collapses in R175E, 
where all the hydrogen bonds with residue E175 are broken (Fig. 2b), increasing the side chain B-factor 
by ∼50% (see Supplementary Table S1 for the list of hydrogen bonds in different arrestin structures from 
pdb database). However, the backbone interactions E175-N…O-R29 and E175-O…N-Y31 involving the 
Cα , as well as the secondary structure elements and positioning of the polar core residues E175 (R175 
in arr-1), D30, D296 and D303 are similar in both arr-1 and R175E with an rmsd of ∼1.24 Å17. Primary 
residues contributing to the polar core are localized on the β -strands (D30, R/E175) and the gate loop 
(D296, D303) that we examined next.
Gate loop. In the crystal structures of arr-1 and other arrestins in basal state, the gate loop residues 
D296, D303 and N305 form a hydrogen-bonding network with R175 (numbering refers to arr-1). In 
contrast, this network does not exist in R175E (Fig. 2b,c). Superposition of R175E on arr-1 shows that 
the gate loop is pushed away from the central residue 175 of the polar core (Cα R/E 175E – Cα D303 
distance is 10.6 Å and 12.2 Å in arr-1 and R175E, respectively) (Fig. 2c). Secondly, side chains of several 
residues in the loop show different rotamers, mostly facing away from the center. An outward shift of 
the loop and lack of the hydrogen bonding network opens the polar core cleft slightly. Side chain of 
E175 also faces away from the center and is now exposed. Not surprisingly, the Cα position of residue 
175 remains unchanged, which is located relatively fixed on the β -strand X (residues 169–178) (Fig. 1).
Figure 2. Structural differences between arr-1 (PDB ID 3UGX, molecule A) and R175E. (a) The hydrogen 
bond network in arr-1 around Arg 175 linking residues (shown in stick model) from polar core, gate loop 
and the C-tail (shown in green). Hydrogen bonds are shown as blue dotted lines (for clarity, h-bonds shown 
are ≤ 3.2 Å) (b) R175E polar core region shows a complete collapse of the hydrogen bond network (c) 
superposition of arr-1 and R175E showing differences in the polar core region. Gate loop in R175E shows 
an outward shift and the residues of this loop show different rotamers. Additionally, E175 is exposed, and 
the side chain of R29 is truncated beyond Cβ position due to missing electron density. (d) Superposition 
of arr-1 and R175E showing the finger loop and loop 139. Both, α (extended, as in molecule B in PDB ID 
3UGX, orange) and β (bent, as in molecule A in PDB ID 3UGX, gold) conformations are seen in arr-1. In 
R175E, no electron density could be traced for residues 69 to 75 of the loop that is likely disordered (shown 
in dotted blue line). (e) Anchoring of C-tail and three-element interaction in arr-1 showing hydrogen-bond 
interactions between residues from the polar core region, the N-terminus and the C-tail. (f) In R175E, 
showing absence of hydrogen bond interactions between the polar core residues and the C-tail as well as 
surface exposure of the residues. Also, note the antiparallel positioning of the C-tail in panel e where R382 
is the terminal residue in arr-1 crystal structure to participate in the polar core network. Disruption of 
polar core in R175E releases R382, a major constraint that once released leads to enhanced C-tail flexibility. 
Energetically, this in turn can initiate the disruption of further H-bond interactions (between the C-tail 
residues 380, 379, 378 with the central residue R29; Supplementary Table S2), causing the R29 side chain to 
disorder.
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On the receptor-interface on concave side, loops containing residues 139, 157 and 344 correspond 
to the ‘plastic’ regions of arr-1 that show high flexibility in both arr-1 and P-Rh* complex18, as well as 
in distinct conformations in monomers of crystal tetramer (Supplementary Fig. S3)19. These loops in 
R175E show conformations similar to that in arr-1 (Fig. 2d). Several of the loops have been previously 
reported to play a role in receptor binding7,20. Specifically, these include the finger loop (residues 68–79), 
loop 139 or middle loop (residues 133–142), and lariat loop (283–305, including the gate loop residues 
296–305 described above).
Finger loop. Significance of the finger loop in the arrestin-receptor binding interface has been estab-
lished through biochemical and structural data7,18,19,21. Located between the two domains, the loop is 
anticipated to bind within the crevice that opens up on the cytoplasmic face of the receptor during TM6 
and TM5 movements22. Conformational flexibility in the finger loop (residues 68–79) has been proven to 
be essential for arrestin to adopt high affinity binding to the receptor18,23–27. In arr-1 structure, this loop 
attains two conformations: extended as in α -conformer, and folded-in towards the concave surface of the 
N-domain as in β conformation8,10,13. In R175E, residues 69–75 in the loop could not be traced in the 
electron density map and are likely to be disordered (Fig. 2d). This is unexpected as residues of the finger 
loop are not in direct contact with the polar core. Additionally, the loop is solvent-exposed and shows no 
Data collection
 Radiation source ESRF ID23-1
 Wavelength (Å) 0.97902
 Resolution range (Å) 41.64 – 2.7 (2.83 – 2.7)**
 Space group P 21 21 21
Cell dimensions 
 a,b,c (Å) 66.37, 72.31, 79.4
 Total reflections 83633 (9579)
 Unique reflections 10993 (1430)
 Multiplicity 7.6 (6.7)
 Completeness (%) 99.92 (99.91)
 〈 I/σ (I)〉 10.8 (2.5)
 Wilson B-factor (Å2) 38.6
 R-merge 0.217 (0.924)
 R-measured 0.234 (1.005)
Refinement
 Resolution range (Å) 41.64-2.7 (2.97–2.7)**
 Rwork 0.1938 (0.2742)
 Rfree 0.2414 (0.3214)
 No. of atoms 2677
 Protein 2608
 Protein residues 343
 Ligands 15
 Solvent 54
R.m.s. deviation from ideal
 Bonds (Å) 0.01
 Angles (°) 1.01
 Mean B-factor (Å2) 44.1
 Protein 44.2
 Ligands 63.0
 Solvent 34.6
Ramachandran statistics (%)
 Favored regions 98
 Outliers (%) 0
Table 1. Data collection and refinement statistics on arrestin R175E*. *Merge of two datasets. **Values in 
parentheses are for the highest resolution shell.
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crystal contacts. Just recently, crystal structure of rhodopsin-arrestin complex has been published where 
the arrestin finger loop clearly adopts a α -helical conformation and forms the primary interface between 
the two proteins where it interacts extensively with the C-terminus of TM7, the N-terminus of helix 8 
and the intracellular loop 1 (ICL1) of rhodopsin28 (Supplementary Fig. S4). The α -helical conformation 
of the finger loop peptide analogues bound to rhodopsin was shown previously by solution NMR29 and 
crystallography22. Both, missing electron density as seen in R175E mutant and conformational variabil-
ity of the finger loop as in various crystal structures are suggestive of the flexible nature that is likely 
to reflect the activation dependent changes13–15, as now evident from the rhodopsin-arrestin complex 
structure28. Interestingly, a common feature seen in the crystal structures of pre-activated arrestins, the 
rhodopsin-arrestin complex and the R175E mutant is also disruption of the polar core (Table S1). Both, 
disordered finger loop and a completely disrupted polar core in R175E are thus consequences of the 
point mutation.
Anchoring of the C-tail and three-element interaction. The C-terminal residues 371–386 in 
the basal state structure are folded onto the polar core region, blocking binding of the phosphorylated 
receptor. Anchoring of the C-tail mainly takes place via interaction between residues of the C-tail (most 
conserved are R382, F380, E378), the polar core (D30, D303, R175), the arginine switch (R29) and the 
N-terminal β -strand I (here C-tail residues form an anti-parallel β -strand XX) (Fig. 2e) (Supplementary 
Table S2). As mentioned elsewhere, the basal state of arr-1 is stabilized mainly by the polar core and the 
three-element interaction, where the latter includes residues from β -strand I, α -helix I, and β -strand XX 
(Fig. 1a).
Compared to arr-1, a major structural difference in R175E is the absence of electron density for 
C-terminal residues (361–404) that includes the C-tail residues. The region, in general, is flexible30 as res-
idues 362–370 and its equivalents could not be resolved in all previously published arrestin structures8–12. 
The disordered residues form the linker region connecting the C-domain and the C-tail, where the latter 
binds along the N-domain and is the only ordered part of the C-terminus in the crystal structures of 
full-length arrestins (Fig. 1a, 362–370 are shown in dashed line). As the point mutation was introduced 
in the wild type background, we first checked for the presence of C-terminal residues in the crystals 
(Supplementary Fig. S5). SDS-gel and mass spectrometry (MALDI-TOF) analysis (data not shown) of 
R175E crystals show the presence of full-length protein, with no indications of proteolysis. Additionally, 
results of size-exclusion chromatography (Supplementary Table S3) and SAXS analysis of arr-1, p44 and 
R175E are also suggestive of the presence of R175 in full-length in solution.
Release of the C-tail plays an important role in initiation of arrestin activation that precedes high affin-
ity binding of the phosphorylated C-terminus of receptor7,21,30–32. In the crystal structure of arr-1, residue 
R382 in the C-tail shows hydrogen bonding with residues R29, D30, D303 and L173 in and around the 
polar core (Fig. 2e). Of these residues, R29 is hydrogen bonded to E378, E379, F380 and R382, interac-
tions that are majorly responsible for anchoring of the C-tail as in the basal state. Interestingly, the side 
chain of R29 is disordered in R175E as it could not be traced in the electron density map beyond the Cβ 
position (Fig. 2f). The dynamic nature of the R29 side chain is to be seen in the reported arrestin struc-
tures, where it adopts different rotamers (Supplementary Fig. S6). In our previously reported structure of 
the truncated splice variant p44 arrestin, R29 points ‘in’ the polar core where it interacts with D30 and 
R175, taking place of the missing C-tail residue R38213. In contrast to the side chain flexibility of R29, the 
backbone interaction R29-O…N-E175 is conserved in all arrestin structures including R175E structure, 
suggesting importance of the close proximity of the two residues in arrestin function. Recently, R29 was 
suggested to control the C-tail exchange mechanism where the C-tail of arrestin is released with several 
charged residues exposed for binding of the phosphorylated C-terminus of receptor33. These authors 
performed an extensive mutagenesis study, where mutant R29A was shown to be the weakest binder 
to P-Rh*. Furthermore, the equivalent residue of R29 in β -arrestin is in direct contact with the GPCR 
phosphopeptide in the recently published crystal structure of β -arrestin-1-peptide complex, confirming 
this region as binding site for the phosphorylated receptor15. No structure coordinates were reported for 
several C-terminal amino acids (362–393, β -arrestin-1 numbering) in the same structure and are pre-
sumably flexible. Likewise, no electron density could be detected for the C-terminal residues (362–392) 
in the crystal structure of rhodopsin-arrestin complex28. In R175E, collapse of the hydrogen bond net-
work in the polar core (R382 is no longer anchored here) is likely to cause release of the C-tail, breaking 
the interactions with R29, consequently increasing the side chain flexibility (Fig. 2f).
Small angle X-ray scattering (SAXS). SAXS analysis was performed to determine the oligomeric 
state and low-resolution shape of R175E in solution. For comparison, arr-1 and the truncated splice 
variant p44 were measured under identical conditions as described in methods. The molecular mass 
determined from the Porod volume and ab initio modeling is 43.5, 45.4 kDa and 81.2 for R175E, p44, 
and arr-1, respectively (The calculated molecular mass from the amino acid sequence for R175E, p44 and 
arr-1 dimer is 47.1, 41.1, and 94.2 kDa) (Fig. 3). As indicated from the analytical size-exclusion chroma-
tography (Supplementary Table S3), SAXS results confirm that the wild type arr-1 is dimeric, with the 
best fit comprising A/D chains of the crystal structure PDB ID 3UGX as judged by the χ -value, the RG, 
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and the ab initio model. (χ -value is defined as χ = ∑ 




σ
( ) − ( )
( )N q
I q I q
q
1
2
m , where I(q) and σ(q) are the 
measured intensities and errors, respectively, I(q)m are the calculated intensities from the structural 
model, and N is the number of data points). The measured Guinier radius RG of arr-1 is 37.4 ± 0.1 Å. The 
RG of 3UGX monomer, the 3UGX A/B chains and the 3UGX A/D chains is 27.9, 41.6 and 35.5 Å, respec-
tively. The fits yielded corresponding χ -values of 32.2, 10.3, and 5.1 for the monomer, the A/B dimer, 
and the A/D dimer, where a lower value of χ indicates a better fit (Fig. 3a).
In contrast, mutant R175E and p44 are monomeric with experimentally determined RG values of 
28.8 ± 0.2 Å and 31.9 ± 0.2 Å. The corresponding RG values calculated from the crystal structures are 28.0 
and 27.9 Å. It is interesting that the crystal structures of both proteins contain one monomer per asym-
metric unit current work,13. In case of R175E, the data fits best with the C-tail kept flexible (χ = 0.67 for 
the structure with flexible C-tail vs. χ = 1.70 for the crystal structure only) (Fig. 3b). The calculated RG 
of 29.1 Å of the structural ensemble with flexible C-tail is also closer to the measured RG of 28.8 Å. This 
is in agreement with the ab initio model of R175E, which is more extended in the region of the flexible 
C-tail when compared to that of p44 (Fig. 3b,c).
Structural differences between R175E and the ‘active’ crystal structures. One of the properties 
reported in the recently published crystal structures of arrestin in ‘active’ state is a 21° rotation between 
N and C domains14,15. Compared to arr-1, R175E shows a 7.5° rotation (Fig. 1c). A possibility of rotation 
between the domains was previously suggested in molecular modeling34 and truncation experiments in 
the inter-domain hinge region35. Relative movement of domains is supportive of the ‘clam-shell’ model 
where these transitions are required for arr-1 to bind the receptor in ‘high-affinity’ state7. In contrast, 
using site-directed spin labeling and double electron-electron resonance, Kim et al. measured long-range 
(~17–60 Å) intramolecular distances in arr-1 in solution in the presence of P-Rh* to show that the rela-
tive position of N and C domains remains largely unchanged19. Similarly, no evidence of domain move-
ment could be seen in non-visual arrestins31, thus working against the ‘clam-shell’ model. An important 
Figure 3. Characterization in solution by small angle X-ray scattering (SAXS). (a) arr-1, (b) R175E 
and (c) p44 (as control). Upper panels show experimental SAXS curves (black circles) overlaid with the 
theoretical scattering curves calculated from the respective crystal structures. In (a), X-ray crystal structure 
(PDB ID: 3UGX) used are of arr-1 monomer (blue line: molecule A), and two possible dimers (green line: 
molecule A and B; red line: molecule A and D); in (b) crystal structure of the R175E monomer including 
the flexible C-terminus (red line), and without the flexible C-terminus (dashed blue line); and in (c) crystal 
structure of p44 (PDB ID: 3UGU) monomer (red line). Middle panels show the respective experimental 
data and the fits in Kratky-plots. Lower panels show the respective ab initio models (cyan, shown in mesh) 
determined by SAXS. Ribbon structures of the respective crystal structures: Gold, dimer with molecules A 
and D (PDB ID: 3UGX) in (a); blue R175E in (b), and magenta p44 (PDB ID: 3UGU). Orientation in (b) 
and (c) are as in Fig. 1. The dimer of arr-1 in (a) is positioned such that molecule A on the top is oriented 
as in Fig. 1c.
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clue comes from the first crystal structure of rhodopsin-arrestin complex28 that reveals a ~ 20° rotation 
between N and C domains, as seen previously in the two ‘activated’ arrestins14,15. The domain movement 
opens a cleft in arrestin to accommodate the short helix formed by the second intracellular loop of 
rhodopsin (Supplementary Fig. S4). The physiological relevance of the structural model of the complex 
was extensively validated by the authors using double electron-electron resonance, hydrogen-deuterium 
exchange mass spectrometry, cell-based rhodopsin-arrestin interaction assays and site-specific disulfide 
cross-linking experiments. The domain movement seen in R175E and the three activated arrestins is 
suggestive of its role in arrestin activation mechanism that may apply to all members of arrestin family.
Other structural differences between R175E and the active states are seen in the gate, finger and the 
middle loops (loop 139)14,15 (Supplementary Figs S4, S7). Role of the 139 loop has been previously pro-
posed in stability and binding selectivity of arr-136. Using double electron-electron resonance (DEER) 
data, large conformational changes in the loop 139 were reported in arr-119, but not in β -arrestin where 
the loop was suggested to be highly flexible in both the basal and active states31. Furthermore, functional 
mapping of arr-1 at single amino acid resolution showed no significant binding effects to Rh* when res-
idues of this loop were mutated to alanine33. However, similarity of the middle loop conformation in the 
pre-activated arrestins and in the rhodopsin-arrestin complex as well as its position at the interface in 
the later structure confirms its role in receptor binding. As shown in supplementary Fig. S4, in order to 
bind rhodopsin, the loop as in the basal state needs to move up to avoid the steric clashes. This in turn 
will have an influence on the gate loop conformation as seen for the three ‘activated’ arrestin structures 
(Supplementary Fig. S7).
Release of C-tail is predicted to expose the residues of gate loop (296–305) for interaction with the 
activated receptor7. In R175E, the C-tail is disordered exposing the lariat loop residues, and yet the overall 
conformation remains similar to that of arr-1. The loop is mostly stabilized by hydrogen bonding within 
intra-loop residues (also see Table S1 for a detailed list of hydrogen bonds in the polar core for various 
arrestin structures deposited in pdb database). Surprisingly, the gate loop residues show no contact with 
rhodopsin in the complex structure28. As mentioned elsewhere, conformational flexibility in the finger 
loop residues has been established both structurally and biochemically. Residues of the finger loop are 
disordered in R175E. It is likely that in the pre-activated state the loop becomes highly flexible ‘search-
ing’ for the correct binding site in the receptor, which is stabilized once bound to the receptor as seen in 
the rhodopsin-arrestin crystal structure where it adopts a α -helical conformation28. Notably, crystals of 
pre-activated p44 and β -arrestin with the finger loop in extended conformations were obtained in the pres-
ence of the ligands opsin and phosphopeptide V2Rpp-synthetic antibody fragment Fab30, respectively14,15. 
Crystallization of R175E was performed without any ligand. The 20° rotational change in domains as well as 
significantly different loop conformations seen for the three above-mentioned loops in case of ‘pre-activated’ 
arrestins14,15 is likely induced by the presence of ligand protein/peptide, as revealed in the crystal structure 
of rhodopsin-arrestin complex28. Additionally, the gate loop residues in the β -arrestin–peptide complex 
show interactions with the peptide bound to arrestin as an antiparallel β -strand replacing the C-tail15.
Conformation of R175E arrestin: basal, pre-active or active? In the current model of arrestin 
activation, interaction of receptor-attached phosphates with polar core residues results in conformational 
changes including breaking of the three-element interaction and release of C-tail, allowing formation of 
the initial receptor-arrestin complex. Subsequently, further structural changes in arrestin cause its transi-
tion to high-affinity binding state7,20. Previous mutagenesis studies have shown that like R175E, mutation 
of residues in the polar core, C-tail and those involved in the three-element interaction also result in 
pre-active arrestins that bind light-activated rhodopsin irrespective of its phosphorylation state3. The 
most likely explanation common to these mutations is the release of a stereochemical constraint respon-
sible to keep arrestin in its basal state. For the highly conserved ion pair R175 and D296, it was proposed 
that neutralization or charge reversal of the residues result in mutants that mimic the effect of phosphate 
groups from the receptor, allowing them to bypass the need of receptor phosphorylation3. Formation of 
this state would involve structural rearrangements in the polar core, C-tail and three-element interaction. 
Additionally, the authors speculated a change in position of the N- and C- domains relative to each other 
for arrestin to achieve the high-affinity binding state. The structure of R175E presented here is the first 
structure report of an arrestin with mutation in the polar core that shows a completely disrupted hydro-
gen bond network in the polar core (also see Table S1), a 7.5° rotation between N- and C- domains, and 
a ‘free’ C-tail. Furthermore, the displacement of C-tail residues causes an increase in the overall positive 
electrostatic potential and exposure of the key phosphor-sensor residues (Supplementary Fig. S8), allow-
ing it to bind the receptor irrespective of its phosphorylation state as has been previously reported for 
the truncated arrestins13,14,34. As the mutations in case of other pre-active mutants of arrestin are located 
in the polar core, the three-element or the C-tail regions3, it can be speculated that the conformational 
rearrangements and the activation mechanism in the mutants would be similar to R175E.
Taken together, the structural features of R175E and its differences to the basal and ‘active’ states 
tempt us to propose that the structure presented with disrupted polar core and three-element interac-
tion with a ‘free’ C-tail represents an intermediate activation state prior to formation of the high-affinity 
ligand complex20. Consistent to the arrestin activation model, the first step involves phophosensor inter-
action and the release of C-tail, breaking the three-element interaction. This is then followed by the 
ligand-induced conformational changes for the formation of ‘high-affinity’ state bound to the receptor. 
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This includes a ~20° rotation movement between N and C domains, which opens a cleft between the 
middle loop (loop 139) and the C-loop (loop 250), allowing binding of the finger loop to the rhodopsin28. 
Additional structural changes are expected to take place for optimal binding of the receptor such as seen 
in the loop conformations in case of rhodopsin-arrestin28 and β -arrestin phosphopeptide complexes15.
Methods
Expression, purification and crystallization of R175E mutant arrestin. Recombinant mutant 
R175E was generated using oligonucleotide-directed mutagenesis by introducing the point muta-
tion in arr-1 as described previously37. The mutagenesis primer used for the PCR amplification was: 
5′-CGT TTG CTG ATC GAG AAG GTA CAG-3′ . The resulting mutated R175E gene was verified by 
sequencing and cloned into the vector pYEX-BX (Clontech, Heidelberg). Large-scale expression and 
purification of recombinant arrestins R175E, arr-1 and p44 were carried out in Saccharomyces cerevisiae 
F11 α strain as described before37. Purified R175E was concentrated to a protein concentration of 13 mg/
mL, and crystallization setups were performed using the vapor-diffusion method. Crystals were grown in 
2-μ l sitting drops (1 μ l protein + 1 μ l reservoir solution) against 100 mM Tris (pH 7.5) and 8–18% (w/v) 
polyethylene glycol 4000 at 19 °C, where the first crystals appeared within 8–10 days that were allowed 
to grow further for another two weeks.
Data collection. The X-ray diffraction datasets were collected at 100 K. Prior to cryo-cooling, the 
crystal was soaked stepwise in reservoir solution containing up to 20% (v/v) glycerol. Native data were 
recorded at the beamline ID23-1 of the ESRF (Grenoble, France) tuned to a wavelength of 0.979 Å on a 
PILATUS 6M-F detector (DECTRIS). The data collection strategy taking radiation damage into account 
was based on calculations using the program BEST38. Data processing including reflections up to 2.7 Å 
resolution was carried out using XDS39 and AIMLESS (CCP4)40.
Structure determination. The structure was determined by molecular replacement using MOLREP 
(CCP4) with a merged native dataset. The search model was modified from the arr-1 model PDB ID 
3UGX with the point mutation E175, which was reduced to alanine for control purpose. Crystals were 
found to contain one molecule per asymmetric unit, corresponding to a Matthews coefficient of 2.03 Å3/
Da and a solvent content of 39.3%. Following rigid-body refinement using the PHENIX package41, the 
model was improved in an iterative manner, including several cycles of positional, isotropic tempera-
ture factor and TLS refinement with PHENIX and manual rebuilding using the program COOT42. For 
statistics on data collection and refinement refer to Table 1. According to Ramachandran plot generated 
with Molprobity (PHENIX), the model exhibited good geometry with none of the residues in disallowed 
regions. Relative rotation between the domains in R175E and wild type arr-1 (3UGX chain A) were com-
puted using algorithm Hingefind43 that resulted in an effective rotation angle of 7.53° with the relative 
error of 0.065%.
Small angle X-ray Scattering. Small angle scattering was measured on the BioSAXS beamline 
BM29 at the ESRF44. The temperature was kept at 10 °C throughout the experiment. Ten individual 
frames with 1 s exposure time were recorded, while the samples were continuously purged through a 
quartz capillary. The frames without radiation damage were averaged, and contribution of the buffer was 
subtracted from measured intensities of the protein solution. Data were scaled by the measured protein 
concentrations and extrapolated to infinite dilution. Three concentration series were measured (arr-1: 
1.9, 3.0 and 8.5 mg/mL, R175E: 0.4, 0.9 and 1.7 mg/mL, p44: 1.0, 2.0 and 4.6 mg/mL) in buffer containing 
10 mM HEPES, 150 mM NaCl, pH 7.5.
SAXS data were analysed using the programs available within the ATSAS software package45. 
Scattering curves of the crystallographic structures were calculated and fitted to the experimental SAXS 
data using the computer program CRYSOL. The distance distribution function P(r) and the Porod vol-
ume of the protein were determined with the programs GNOM and DATPOROD, respectively. Ab initio 
models were generated using the DAMMIF program where twenty models were generated, averaged and 
the filtered model was used. The envelope function of the filtered ab initio model was visualized using 
the SITUS package46. The molecular mass was estimated from the excluded volume of the filtered ab 
initio model and from the Porod volume using division factors of 2 and 1.7, respectively45. Flexibility of 
the C-tail of R175E arrestin was modelled using the program EOM. A large pool of 10,000 random-like 
conformations of the tags and the flexible C-tail attached to the crystal structure was generated. Positions 
of the residues 69–75 (loop V-VI) were taken from the open α -conformation of arr-1. Consecutively, 
a representative conformational ensemble was selected, which best describes the measured data. In the 
small-angle range, no significant differences are observed between the α or the β finger loop conforma-
tion in the SAXS analysis of arr-1.
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